• Aesthetic AuthorityAesthetic Authority
  • Dermatology Times
Dermatology Times and Multimedia Medical, LLC
Dermatology Times and Multimedia Medical, LLC
Spotlight
American Academy of DermatologyAmerican College of Mohs Surgery MeetingPrecision Medicine and BiologicsRevolutionizing Atopic DermatitisInnovations in the Treatment of Atopic DermatitisPerspectives on Generalized Pustular PsoriasisInside the ClinicMelanoma Awareness MonthNew Wave Dermatology ConferenceReadout360Society of Dermatology Nurse Practitioners
Topics
View MoreAcneAnti-AgingAtopic Dermatitis Hair & ScalpImpetigoNP and PAPsoriasis RosaceaSkin Cancer (Melanoma)Skin Cancer (Non-Melanoma)Women's Health
News
Device Technology
Drug Watch
Legal
Lifestyle
NP and PA
Practice Management
Media
Around the Practice
Dermview
Dermview: Vitiligo
Editorial Board News
Expert Interviews
Inside the Clinic
Medical World News
Podcasts
Readout360
Viewpoints
Webinars
Conferences
Conference Coverage
Conference Listing
Publication
Dermatology Times
CME/CE
Resources
Image IQ
Interactive Tools
Job Board
Partnerships
Polls
Sponsored
Editorial Board
Subscribe
eNewsletter
Print Subscription
  • Advertise
  • Contact Us
  • Job Board
  • Do Not Sell My Information
  • Terms and Conditions
  • Privacy Policy
  • About Us

© 2022 MJH Life Sciences and Dermatology Times and Multimedia Medical, LLC. All rights reserved.

Spotlight
  • American Academy of Dermatology
  • American College of Mohs Surgery Meeting
  • Precision Medicine and Biologics
  • Revolutionizing Atopic Dermatitis
  • Innovations in the Treatment of Atopic Dermatitis
  • Perspectives on Generalized Pustular Psoriasis
  • Inside the Clinic
  • Melanoma Awareness Month
  • New Wave Dermatology Conference
  • Readout360
  • Society of Dermatology Nurse Practitioners
TopicsSee All >
  • Acne
  • Anti-Aging
  • Atopic Dermatitis
  • Hair & Scalp
  • Impetigo
  • NP and PA
  • Psoriasis
  • Rosacea
  • Skin Cancer (Melanoma)
  • Skin Cancer (Non-Melanoma)
  • Women's Health
  • Advertise
  • Contact Us
  • Job Board
  • Do Not Sell My Information
  • Terms and Conditions
  • Privacy Policy
  • About Us
  • MJHLS Brand Logo

© 2022 MJH Life Sciences™ , Dermatology Times and Multimedia Medical, LLC. All rights reserved.

Understanding the Black Box Warnings for JAK Inhibitors

Linda Stein Gold, MD, and Matthew Zirwas, MD, provide a discussion on the role of JAK inhibitors in inflammatory diseases.

EP. 1: An Overview of JAK Inhibitors

December 22nd 2021

Linda Stein Gold, MD, provides an overview of the four JAK inhibitors currently available for treating inflammatory diseases.

EP. 2: Safety and Efficacy of JAK Inhibitors

January 3rd 2022

Key opinion leaders explain the box warnings and safety profiles of JAK inhibitors.

EP. 3: Reviewing Clinical Trial Data for JAK Inhibitors

January 5th 2022

Matthew Zirwas, MD, breaks down the safety of JAK inhibitors based on clinical trial data.

EP. 4: Risk of Systemic Absorption with JAK Inhibitors

January 17th 2022

Clinicians provide insight into the risk of high systemic absorption levels with JAK inhibitor treatments.

EP. 5: Treating Atopic Dermatitis with Ruxolitinib

January 19th 2022

Dr Matthew Zirwas describes his experience using JAK inhibitor ruxolitinib in his clinical practice.

EP. 6: Advice for Clinicians on JAK Inhibitors

January 26th 2022

Linda Stein Gold, MD, and Matthew Zirwas, MD, share some advice for clinicians on how to discuss JAK inhibitors with patients.

EP. 7: How to Explain JAK Inhibitor Warnings to Patients

February 2nd 2022

Experts outline strategies for patient conversations around the black box warning.